MYH4: A Potential Drug Target and Biomarker for Muscle and Disease

Target Name: MYH4

NCBI ID: G4622

MYH4

MYH4: A Potential Drug Target and Biomarker for Muscle and Disease

Myosin Heavy Chain 2B (MYH4) is a protein that is expressed in muscle cells and is involved in muscle contraction and relaxation. It is a key component of the myosin filament, which is the protein structure that makes up the muscle cell.MYH4 has been identified as a potential drug target and is the focus of research at the University of California, San Diego School of Medicine.

MYH4 is a 21-kDa protein that is expressed in muscle cells and is involved in the regulation of muscle contraction and relaxation. It is a key component of the myosin filament, which is the protein structure that makes up the muscle cell. When muscle cells contract, the myosin filaments pull on the muscle fibers, allowing the muscle to be extended. When the muscle fibers relax, the myosin filaments return to their original position, allowing the muscle to be relaxed.

MYH4 is involved in the regulation of several key processes that are important for muscle function. It plays a role in the regulation of muscle contractions, which are the movements that are necessary for muscle growth and maintenance. It also plays a role in the regulation of muscle relaxation, which is necessary for muscle to recover after exercise.

MYH4 is a protein that is expressed in muscle cells and is involved in the regulation of muscle contraction and relaxation. It is a key component of the myosin filament and plays a role in the regulation of several key processes that are important for muscle function. As a result, it has been identified as a potential drug target.

MYH4 has been shown to play a role in several diseases, including heart disease, diabetes, and neurodegenerative diseases. It is also been shown to be involved in the regulation of muscle contractions and to play a role in the development of muscle diseases.

In addition to its potential role as a drug target, MYH4 is also being studied as a biomarker for several diseases. For example, it has been shown to be elevated in the blood of patients with heart disease and has been used as a biomarker for heart disease in several studies. It has also been shown to be elevated in the blood of patients with diabetes and has been used as a biomarker for diabetes in several studies.

MYH4 is also being studied as a potential biomarker for neurodegenerative diseases. It has been shown to be elevated in the brain tissue of patients with Alzheimer's disease and has been used as a biomarker for neurodegenerative diseases in several studies.

In conclusion, MYH4 is a protein that is expressed in muscle cells and is involved in the regulation of muscle contraction and relaxation. It is a key component of the myosin filament and has been identified as a potential drug target and biomarker for several diseases, including heart disease, diabetes, and neurodegenerative diseases. Further research is needed to fully understand the role of MYH4 in these diseases and to develop effective treatments.

Protein Name: Myosin Heavy Chain 4

Functions: Muscle contraction

The "MYH4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYH4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets